CIK 0001873835
- Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454869378
- Phone
- +1 888-958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO and Chairman bought 2,500 shares at $5.00 ($12,500)
- 4 Open-market buy Director bought 50,000 shares at $5.00 ($250,000)
- 4 Open-market buy Scientific Co-Founder bought 5,200 shares at an average $4.78 ($24,834)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $5.00 ($10,000)
- 4 Open-market buy Director bought 25,000 shares at $5.00 ($125,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 5 of 5 · 96 filings